Zantac

The United States Food and Drug Administration requested manufacturers immediately withdraw all prescription and over-the-counter ranitidine (Zantac) products from the U.S. market due to a carcinogenic contaminant N-Nitrosodimethylamine (NDMA). Reviews of studies indicate that NDMA levels in ranitidine increase over time and when stored at higher than room temperature, resulting in exposure to unacceptable levels of the carcinogen. As a result of the withdrawal request, ranitidine products are no longer available for sale in the U.S.

TV Commercials

Infomercials

913480005_295x166 (1)

Landing Pages

Social

Paid Search

CAMG has thousands of spots and infomercials that can be branded for your firm. Reach out to us for the latest creative offline and online examples*.
*Examples shown are not always current examples.

Request Samples

* These fields are required.

The CAMG Legal Marketing Index®. Significantly increase your marketing success, on us.

CAMG’s Legal Marketing Index® offers unprecedented reporting and comprehensive analysis of real-time data. Because more intelligent marketing decisions mean a better ROI.

Scroll to Top